# The Effect of Aprepitant Reducing Postoperative Nausea and Vomiting

> **NCT05772676** · PHASE4 · UNKNOWN · sponsor: **Hospital General Tlahuac** · enrollment: 400 (actual)

## Conditions studied

- Obesity
- Nausea and Vomiting, Postoperative

## Interventions

- **DRUG:** Aprepitant
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05772676
- **Lead sponsor:** Hospital General Tlahuac
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-04-01
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2023-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05772676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05772676, "The Effect of Aprepitant Reducing Postoperative Nausea and Vomiting". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05772676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*